| protein
| growth factor receptor-bound protein 2, GBR2 |
|
Crk-associated tyrosine kinase substrate p130Cas  |
|
talin 1, TLN1  |
|
Rho GTPase activating protein 26, ARHGAP26  |
|
neural precursor cell expressed, developmentally down-regulated 9, NEDD9  |
|
Syk protein-tyrosine kinase, Syk  |
|
protein tyrosine kinase 2 beta, PTK2B  |
|
transforming growth factor beta 1 induced transcript 1, TGFB1I1  |
|
c-Cbl-associated protein, CAP  |
|
Janus kinase 2, JAK2  |
|
insulin receptor substrate 1, IRS1  |
|
embryonal Fyn-associated substrate, Efs  |
|
growth factor receptor-bound protein 7, GBR7  |
|
phosphatase and tensin homolog, PTEN  |
|
PDGF- and EGF-receptor (PDGFR and EGFR) signalling complexes  |
|
EPH receptor A2, EPHA2  |
|
polycystic kidney disease 1, PKD1 |
|
transforming growth factor beta 1 induced transcript 1, TGFB1I1  |
|
interaction between the PH domain of Etk and the FERM domain of FAK  |
|
Ezrin, EZR  |
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1, ASAP1  |
|
c-Jun N-terminal kinase (JNK)/stress activated protein kinase-associated protein 1, JSAP1  |
|
NCK adaptor protein 2, NCK2  |
|
activates Src family kinases via c-Src SH2/SH3 interactions  |
|
triple functional domain (PTPRF interacting), TRIO  |
|
protein inhibitor of activated STAT 1, PIAS1  |
|
calcium- and integrin-binding protein, CIB  |
|
potassium large conductance calcium-activated channel subfamily M alpha member 1, KCNMA1  |
|
death domain kinase receptor-interacting protein, RIP  |
|
netrin 1, NTN1  |
|
SAP90/PSD-95-Associated Protein-3, SAPAP3  |
|
N-terminal transactivation domain of p53  |
|
dynamin  |
|
tuberous sclerosis complex 2, TSC2  |
|
EPH receptor B2, EPHB2  |
|
vascular endothelial growth factor receptor-3, VEGFR3  |
|
CAS family members and with GIT1, SORBS1 and BCAR3 |
|
MAPK7  |
|
IGF1R (role in phosphorylation, signaling and stability of the IGF1R)  |
|
binding-protein partner for ELK1, a finding that significantly broadens the potential functioning of PTK2 and ELK1  |
|
with ARHGEF11 and ROCK2, cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts  |
|
DLGAP3 and ASAP1  |
|
IGF1R and plays an important role in cancer cell survival  |
|
epithelial membrane protein 2, EMP2  |
|
interactio with CADM1 (PTK2 is its binding partner and effector in shaping growth cones)  |
|
GNB1-mediated FYN activation integrates PTK2 with adherens junctions, preventing persistent endothelial barrier leakiness  |
|
interacting with XIAP (XIAP modulates PTK2 activity through the control of PTK2 phosphorylation) |
|
scaffold and tyrosine kinase protein that binds to itself and cellular partners through its four-point-one, ezrin, radixin, moesin (FERM) domain  |
|
suppression of vimentin intermediate filaments by PTK2 facilitates the assembly of podosome rosettes  |
|
DLC1 binds to the FAT domain of PTK2 through at least some of the FAT sequences that bind paxillin, although it remains possible that other regions of PTK2 may also interact with DLC1  |
|
PTK2 is a novel regulator of SNAIL1-dependent epithelial-mesenchymal transition in embryonic cells  |
|
ABCB1 is involved in regulating BTB dynamics, likely via its interaction with PTK2, which modulates the phosphorylation status of the OCLN/TJP1 protein complex  |